NEWEGG COMMERCE INC (NEGG) Fundamental Analysis & Valuation

NASDAQ:NEGG • VGG6483G2099

Current stock price

37 USD
-0.79 (-2.09%)
Last:

This NEGG fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. NEGG Profitability Analysis

1.1 Basic Checks

  • In the past year NEGG has reported negative net income.
  • In the past year NEGG had a positive cash flow from operations.
  • NEGG had negative earnings in 4 of the past 5 years.
  • NEGG had negative operating cash flow in 4 of the past 5 years.
NEGG Yearly Net Income VS EBIT VS OCF VS FCFNEGG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

  • NEGG has a worse Return On Assets (-11.62%) than 75.81% of its industry peers.
  • Looking at the Return On Equity, with a value of -37.97%, NEGG is doing worse than 62.90% of the companies in the same industry.
Industry RankSector Rank
ROA -11.62%
ROE -37.97%
ROIC N/A
ROA(3y)-11.02%
ROA(5y)-16.12%
ROE(3y)-41.14%
ROE(5y)-43.56%
ROIC(3y)N/A
ROIC(5y)N/A
NEGG Yearly ROA, ROE, ROICNEGG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600 -800 -1K

1.3 Margins

  • NEGG's Gross Margin of 10.64% is on the low side compared to the rest of the industry. NEGG is outperformed by 87.90% of its industry peers.
  • In the last couple of years the Gross Margin of NEGG has declined.
  • The Profit Margin and Operating Margin are not available for NEGG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.12%
GM growth 5YN/A
NEGG Yearly Profit, Operating, Gross MarginsNEGG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. NEGG Health Analysis

2.1 Basic Checks

  • NEGG does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for NEGG has been increased compared to 1 year ago.
  • The number of shares outstanding for NEGG has been increased compared to 5 years ago.
  • The debt/assets ratio for NEGG has been reduced compared to a year ago.
NEGG Yearly Shares OutstandingNEGG Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
NEGG Yearly Total Debt VS Total AssetsNEGG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • NEGG has an Altman-Z score of 4.20. This indicates that NEGG is financially healthy and has little risk of bankruptcy at the moment.
  • NEGG has a Altman-Z score of 4.20. This is amongst the best in the industry. NEGG outperforms 84.68% of its industry peers.
  • NEGG has a debt to FCF ratio of 1.80. This is a very positive value and a sign of high solvency as it would only need 1.80 years to pay back of all of its debts.
  • NEGG's Debt to FCF ratio of 1.80 is fine compared to the rest of the industry. NEGG outperforms 77.42% of its industry peers.
  • NEGG has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
  • NEGG has a better Debt to Equity ratio (0.14) than 66.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.8
Altman-Z 4.2
ROIC/WACCN/A
WACC9.86%
NEGG Yearly LT Debt VS Equity VS FCFNEGG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

  • NEGG has a Current Ratio of 1.25. This is a normal value and indicates that NEGG is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.25, NEGG is in line with its industry, outperforming 47.58% of the companies in the same industry.
  • NEGG has a Quick Ratio of 1.25. This is a bad value and indicates that NEGG is not financially healthy enough and could expect problems in meeting its short term obligations.
  • NEGG's Quick ratio of 0.52 is in line compared to the rest of the industry. NEGG outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.52
NEGG Yearly Current Assets VS Current LiabilitesNEGG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. NEGG Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 27.91% over the past year.
  • The Revenue for NEGG has decreased by -17.46% in the past year. This is quite bad
  • Measured over the past years, NEGG shows a very strong growth in Revenue. The Revenue has been growing by 398.84% on average per year.
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.74%
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-19.59%
Revenue growth 5Y398.84%
Sales Q2Q%12.55%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NEGG Yearly Revenue VS EstimatesNEGG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
NEGG Yearly EPS VS EstimatesNEGG Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 -0.5 -1 -1.5 -2

More info and screens

Find the best growth stocksShow best growing peers

1

4. NEGG Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for NEGG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NEGG Price Earnings VS Forward Price EarningsNEGG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • NEGG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 88.47
EV/EBITDA N/A
NEGG Per share dataNEGG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. NEGG Dividend Analysis

5.1 Amount

  • NEGG does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

NEGG Fundamentals: All Metrics, Ratios and Statistics

NEWEGG COMMERCE INC

NASDAQ:NEGG (3/18/2026, 8:27:09 PM)

37

-0.79 (-2.09%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A
Earnings (Next)04-27
Inst Owners1.13%
Inst Owner Change-83.33%
Ins Owners24.53%
Ins Owner Change0%
Market Cap775.89M
Revenue(TTM)1.24B
Net Income(TTM)-43.33M
Analysts82.86
Price TargetN/A
Short Float %38.28%
Short Ratio4.3
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF 88.47
P/OCF 62.45
P/B 6.8
P/tB 6.8
EV/EBITDA N/A
EPS(TTM)-2.25
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.42
FCFY1.13%
OCF(TTM)0.59
OCFY1.6%
SpS58.92
BVpS5.44
TBVpS5.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.62%
ROE -37.97%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.64%
FCFM 0.71%
ROA(3y)-11.02%
ROA(5y)-16.12%
ROE(3y)-41.14%
ROE(5y)-43.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.12%
GM growth 5YN/A
F-Score5
Asset Turnover3.31
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.8
Debt/EBITDA N/A
Cap/Depr 38.92%
Cap/Sales 0.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.52
Altman-Z 4.2
F-Score5
WACC9.86%
ROIC/WACCN/A
Cap/Depr(3y)114.15%
Cap/Depr(5y)94.02%
Cap/Sales(3y)0.95%
Cap/Sales(5y)0.69%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)27.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-17.46%
Revenue growth 3Y-19.59%
Revenue growth 5Y398.84%
Sales Q2Q%12.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y27.48%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y125.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y363.84%
OCF growth 3YN/A
OCF growth 5YN/A

NEWEGG COMMERCE INC / NEGG Fundamental Analysis FAQ

What is the ChartMill fundamental rating of NEWEGG COMMERCE INC (NEGG) stock?

ChartMill assigns a fundamental rating of 2 / 10 to NEGG.


What is the valuation status for NEGG stock?

ChartMill assigns a valuation rating of 1 / 10 to NEWEGG COMMERCE INC (NEGG). This can be considered as Overvalued.


What is the profitability of NEGG stock?

NEWEGG COMMERCE INC (NEGG) has a profitability rating of 0 / 10.


Can you provide the financial health for NEGG stock?

The financial health rating of NEWEGG COMMERCE INC (NEGG) is 5 / 10.